Monitoren van de veiligheid van medicijnen: European Medicines Agency presenteert eerste rapport aan de Commissie

The European Medicines Agency (EMA) has presented the European Commission with its first report on the tasks it undertook during the first year of application of the EU’s new pharmacovigilance legislation. Responsibility for implementing the new legislation is shared between the European Commission, the national competent authorities and EMA.
The report, which covers the period 2 July 2012 to 1 July 2013, reveals positive results for ensuring the main objectives of the new legislation, i.e. better collection of key information on medicines, improved analysis and understanding of data and information, greater transparency (EU Public Health Nieuwsbrief, 2 mei 2014).
Klik hier voor meer informatie over medicatiebewaking..
Klik hier om het rapport te downloaden (914 kB).

Dit bericht is ook opgenomen in ons maandelijkse overzicht, de NVC Members-only Update. Heeft u vragen, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411.